NewsletterNewslettersEventsEventsPodcasts
Loader
Find Us
ADVERTISEMENT

AstraZeneca to sell Ohio site to biotech firm Resilience

AstraZeneca to sell Ohio site to biotech firm Resilience
AstraZeneca to sell Ohio site to biotech firm Resilience Copyright Thomson Reuters 2022
Copyright Thomson Reuters 2022
By Reuters
Published on Updated
Share this articleComments
Share this articleClose Button

- AstraZeneca is selling its West Chester manufacturing site in Ohio in the United States to biomanufacturing company National Resilience Inc, the company said on Tuesday.

The London-listed drugmaker expects to complete the sale in the first quarter of 2023.

Share this articleComments

You might also like